Health care will get more expensive for some in 2026 – and cheaper for others

People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated ...

Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?

Eli Lilly is the clear leader in the burgeoning weight loss market. Its lineup and pipeline put it well ahead of even its ...
Barchart on MSN

As the FDA approves a Wegovy pill, should you buy, sell, or hold Novo Nordisk stock?

Novo Nordisk A/S ADR (NVO), a trailblazer in the weight-loss revolution, has endured a bruising 2025. The Danish pharma giant ...

Caliway Biopharmaceuticals: Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...

Asian shares are mixed after US stocks drift to more records

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...
The Print

Weight-loss drugs are changing. Here’s what to know about GLP-1s

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...
The Manila Times

Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management ...

US stocks drift to more records on a holiday-shortened day of trading

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. Trading was extremely light ...
The Chosun Ilbo on MSN

Novo Nordisk's oral Wegovy approval fuels obesity drug competition

The era of "oral obesity drugs" has officially begun as Danish pharmaceutical company Novo Nordisk’s obesity treatment received U.S. Food and Drug Administration (FDA) approval in pill form. This is ...